Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · Real-Time Price · USD
30.43
-0.56 (-1.81%)
Mar 12, 2026, 2:50 PM EDT - Market open
Edgewise Therapeutics Market Cap
Edgewise Therapeutics has a market cap or net worth of $3.26 billion as of March 12, 2026. Its market cap has increased by 37.45% in one year.
Market Cap
3.26B
Enterprise Value
2.75B
1-Year Change
37.45%
Ranking
Category
Stock Price
$30.43
Market Cap Chart
Since the IPO on March 26, 2021, Edgewise Therapeutics's market cap has increased from $761.07M to $3.26B, an increase of 328.90%. That is a compound annual growth rate of 34.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 3.32B | 26.54% |
| Dec 31, 2025 | 2.63B | 3.91% |
| Dec 31, 2024 | 2.53B | 264.15% |
| Dec 29, 2023 | 694.27M | 22.85% |
| Dec 30, 2022 | 565.13M | -24.97% |
| Dec 31, 2021 | 753.24M | -1.03% |
| Mar 26, 2021 | 761.07M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alumis | 3.50B |
| Denali Therapeutics | 3.40B |
| Spyre Therapeutics | 3.26B |
| Dyne Therapeutics | 3.26B |
| Tarsus Pharmaceuticals | 3.11B |
| Arcus Biosciences | 3.08B |
| IDEAYA Biosciences | 3.05B |
| Arcutis Biotherapeutics | 3.05B |